Acacia Research: Undervalued Biotech Tentacles
tmoore2021-06-28T12:46:57+00:00In this research note, Formidable takes a deep dive into Acacia Research Corporation (NASDAQ: ACTG), which represents an investment opportunity in secondary private equity, as well as patent litigation (its historical bailiwick). See below for the company’s mission statement, pulled from its website.